| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |